Patients with anemia before the procedure were preliminary treated (even with blood transfusions), thus having acceptable Hb values: in the group who developed CIN, Hb was 12.97±1.7, whereas in those who did not develop CIN, Hb values were 13.18±1.49, which was not significant. This evidence concerns the gene GSTM1 and anemia.